Navigation Links
AxoGen, Inc. Appoints Shawn McCarrey as Vice President of Sales
Date:3/5/2013

Alachua, FL (PRWEB) March 05, 2013

AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today the appointment of Shawn McCarrey to the position of Senior Vice President of Sales, effective immediately. In this role, Mr. McCarrey will participate in the implementation of the Company’s strategic growth initiatives and will lead AxoGen’s sales organization in the United States.

“We are now transitioning into the next phase of the Company’s growth, moving from early adopters to broad usage in surgical peripheral nerve repair,” said Karen Zaderej, Chief Executive Officer of AxoGen. “Shawn’s many years of experience and strong track record of success growing sales of early stage medical technologies will enhance AxoGen’s capabilities and accelerate adoption.    With a strong management team in place and the addition of resources from our recent PDL funding, we are well positioned to drive growth in the peripheral nerve repair market.”
Mr. McCarrey brings to AxoGen more than 15 years of experience as a national medical device sales executive. He most recently served as Executive Vice President of North American Cardiovascular Sales at Bayer Interventional/MEDRAD Interventional. From 1998 through 2009, Mr. McCarrey was rapidly promoted through the executive ranks at Possis Medical, an early commercial stage cardio- and peripheral-vascular company ultimately acquired by MEDRAD Interventional, culminating with his appointment as EVP of Worldwide Sales & Marketing. Earlier in his career, Mr. McCarrey served in sales and sales leadership roles in the Davol and USCI divisions of C.R. Bard.

About AxoGen, Inc.
AxoGen (OTCBB: AXGN) is a regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. The Company’s innovative approach to regenerative medicine has resulted in first-in-class products that will define their product categories. AxoGen’s products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa ECM coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa EMC product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. For more information, visit our website at http://www.axogeninc.com.

AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen’s principal executive office and operations are located in Alachua, FL.

To receive email alerts directly from AxoGen, please click here http://www.axogeninc.com/emailalerts.html.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10497195.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Society for Peripheral Nerve & American Society for Reconstructive Microsurgery 2013 Meetings
2. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting
3. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
4. U.N. Secretary-General Appoints Ray Chambers as His First Special Envoy for the Financing of the Health-Related Millennium Development Goals
5. Private Real Estate Investment Firm, Cohen Asset Management, Inc., Appoints Senior Vice President of Asset Management for East Coast
6. Dynarex Corporation Appoints a New National Sales Manager to Lead their Sales Organization
7. PaloDEx Appoints Brian Broncatti to the Position of Vice President North America
8. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
9. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
10. EPC Group Appoints Industry Veteran to Lead Development Practice Expansion
11. Eagle Village Appoints Mike Mischley and Dani Montini to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: